Page 48 - GALENIKA MEDICAL JOURNAL

34. Hart AR, Luben R, Olsen A, Tjonneland A, Linseisen J, Nagel G, et al. 59. Rackaityte E, Lynch SV. The human microbiome in the 21st century. Nat
Diet in the aetiology of ulcerative colitis: a European prospective cohort Commun. 2020 Oct 16;11(1):5256.
study. Digestion. 2008;77(1):57-64.
60. Roncoroni L, Gori R, Elli L, Tontini GE, Doneda L, Norsa L, et al. Nutrition
35. Glassman MS, Newman LJ, Berezin S, Gryboski JD. Cow's milk protein in Patients with Inflammatory Bowel Diseases: A Narrative Review.
sensitivity during infancy in patients with inflammatory bowel disease. Nutrients. 2022 Feb 10;14(4):751.
Am J Gastroenterol. 1990 Jul;85(7):838-40.
61. Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the
36. Martini GA, Brandes JW. Increased consumption of refined pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018
carbohydrates in patients with Crohn's disease. Klin Wochenschr. 1976 Sep;67(9):1726-38.
Apr 15;54(8):367-71.
62. Williams NT. Probiotics. Am J Health Syst Pharm. 2010 Mar 15;67(6):449-
37. Mayberry JF, Rhodes J, Newcombe RG. Increased sugar consumption in 58.
Crohn's disease. Digestion. 1980;20(5):323-6.
63. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. Overview
38. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary of gut flora and probiotics. Int J Food Microbiol. 1998 May 26;41(2):85-
factors in inflammatory bowel disease. Gut. 1997 Jun;40(6):754-60. 101.
39. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, 64. Gorbach SL. Lactic acid bacteria and human health. Ann Med. 1990
et al. Imbalances in dietary consumption of fatty acids, vegetables, Feb;22(1):37-41.
and fruits are associated with risk for Crohn's disease in children. Am J
Gastroenterol. 2007 Sep;102(9):2016-25. 65. Jonkers D, Stockbrügger R. Probiotics and inflammatory bowel disease.
J R Soc Med. 2003 Apr;96(4):167-71.
40. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, et
al; Epidemiology Group of the Research Committee on Inflammatory 66. Wieërs G, Belkhir L, Enaud R, Leclercq S, Philippart de Foy JM, Dequenne
Bowel Disease in Japan. Dietary risk factors for inflammatory bowel I, et al. How Probiotics Affect the Microbiota. Front Cell Infect Microbiol.
disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2020 Jan 15;9:454.
2005 Feb;11(2):154-63. 67. Borgeraas H, Johnson LK, Skattebu J, Hertel JK, Hjelmesaeth J. Effects
41. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, of probiotics on body weight, body mass index, fat mass and fat
et al. Imbalances in dietary consumption of fatty acids, vegetables, percentage in subjects with overweight or obesity: a systematic review
and fruits are associated with risk for Crohn's disease in children. Am J and meta-analysis of randomized controlled trials. Obes Rev. 2018
Gastroenterol. 2007 Sep;102(9):2016-25. Feb;19(2):219-32.
42. Vijay A, Valdes AM. Role of the gut microbiome in chronic diseases: a 68. Ungaro R, Bernstein CN, Gearry R, Hviid A, Kolho KL, Kronman MP, et al.
narrative review. Eur J Clin Nutr. 2022 Apr;76(4):489-501. Antibiotics associated with increased risk of new-onset Crohn's disease
but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014
43. Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in Nov;109(11):1728-38.
nutrition and health. BMJ. 2018 Jun 13;361:k2179.
69. Bai AP, Ouyang Q. Probiotics and inflammatory bowel diseases.
44. Belkaid Y, Hand TW. Role of the microbiota in immunity and Postgrad Med J. 2006 Jun;82(968):376-82.
inflammation. Cell. 2014 Mar 27;157(1):121-41.
70. Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, et al.
45. Round JL, Palm NW. Causal effects of the microbiota on immune- Interplay of host genetics and gut microbiota underlying the onset
mediated diseases. Sci Immunol. 2018 Feb 9;3(20):eaao1603. and clinical presentation of inflammatory bowel disease. Gut. 2018
Jan;67(1):108-19.
46. Chang JT. Pathophysiology of Inflammatory Bowel Diseases. N Engl J
Med. 2020 Dec 31;383(27):2652-64. 71. Gasbarrini G, Bonvicini F, Gramenzi A. Probiotics History. J Clin
Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th
47. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A Probiotics, Prebiotics & New Foods for Microbiota and Human Health
human gut microbial gene catalogue established by metagenomic meeting held in Rome, Italy on September 13-15, 2015:S116-S119.
sequencing. Nature. 2010 Mar 4;464(7285):59-65.
72. Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J
48. Lee M, Chang EB. Inflammatory Bowel Diseases (IBD) and the Gastroenterol. 2000 Jan;95(1 Suppl):S19-21.
Microbiome-Searching the Crime Scene for Clues. Gastroenterology.
2021 Jan;160(2):524-37. 73. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii
in maintenance treatment of Crohn's disease. Dig Dis Sci. 2000
49. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human Jul;45(7):1462-4.
and Bacteria Cells in the Body. PLoS Biol. 2016 Aug 19;14(8):e1002533.
74. Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, et
50. Ahmad MS, Krishnan S, Ramakrishna BS, Mathan M, Pulimood AB, al. Impact on the composition of the faecal flora by a new probiotic
Murthy SN. Butyrate and glucose metabolism by colonocytes in preparation: preliminary data on maintenance treatment of patients
experimental colitis in mice. Gut. 2000 Apr;46(4):493-9. with ulcerative colitis. Aliment Pharmacol Ther. 1999 Aug;13(8):1103-8.
51. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid 75. Derwa Y, Gracie DJ, Hamlin PJ, Ford AC. Systematic review with meta-
production. Proc Nutr Soc. 2003 Feb;62(1):67-72. analysis: the efficacy of probiotics in inflammatory bowel disease.
52. Caruso R, Lo BC, Núñez G. Host-microbiota interactions in inflammatory Aliment Pharmacol Ther. 2017 Aug;46(4):389-400.
bowel disease. Nat Rev Immunol. 2020 Jul;20(7):411-26. 76. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for
53. Glassner KL, Abraham BP, Quigley EMM. The microbiome and inflammatory bowel disease: a systematic review and meta-analysis. J
inflammatory bowel disease. J Allergy Clin Immunol. 2020 Jan;145(1):16- Crohns Colitis. 2014 Dec;8(12):1569-81.
27.
54. Belkaid Y, Hand TW. Role of the microbiota in immunity and
inflammation. Cell. 2014 Mar 27;157(1):121-41. Konflikt interesa: Nema
55. Lepage P, Colombet J, Marteau P, Sime-Ngando T, Doré J, Leclerc M. Primljeno: 31. 12. 2022.
Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Prihvaćeno: 19. 01. 2023.
Gut. 2008 Mar;57(3):424-5.
Onlajn: 01. 03. 2023.
56. 56. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke
V, Ortner M, et al. Mucosal flora in inflammatory bowel disease.
Gastroenterology. 2002 Jan;122(1):44-54.
57. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and
enteropathogens in the pathogenesis of inflammatory bowel diseases.
Gastroenterology. 2011 May;140(6):1720-28.
58. Zheng D, Liwinski T, Elinav E. Interaction between microbiota and
immunity in health and disease. Cell Res. 2020 Jun;30(6):492-506.

46 DOI: 10.5937/Galmed2305041N